HWELU — Healthwell Acquisition I Share News
0.000.00%
- $173.36m
- $173.59m
Brief: Healthwell Acquisition Announces Termination Of Business Combination With Starton Therapeutics
Brief: Healthwell Acquisition Corp. I Announces Postponement Of The Special Meeting Of Stockholders To Approve The Proposed Business Combination With Starton Therapeutics And Related Transactions
Brief: FDA Authorizes Starton Therapeutics To Proceed With Star-LLD Lenalidomide Phase 1b Clinical Trial
Advisory: Incorrect alerts related to Straton Therapeutics withdrawn
Brief: Starton Therapeutics Inc. And Healthwell Acquisition Corp. I To Combine And Create Publicly Traded Leader In Proprietary Continuous Delivery Technology For Cancer Treatments
Brief: Healthwell Acquisition Corp. I Announces Closing Of $250 Mln IPO
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Healthwell Acquisition Corp I Announces Pricing Of Initial Public Offering